Israel-US bridge Bridge Investment Fund focuses on Israeli medical device companies seeking US market entry and clinical validation, presenting a clear target for vendors looking to expand to the US with strategic support.

US market access With dual offices in Cleveland and Tel Aviv and strong ties to US health care institutions, Bridge can facilitate partnerships, pilots, and sales channels for medtech firms aiming for US adoption.

early clinical stage Portfolio preference appears for companies with completed initial clinical trials, indicating a readiness to scale with US-based regulatory, reimbursement, and commercialization expertise.

low fundraising footprint Bridge operates with a lean team and modest revenue, suggesting a niche, relationship-driven sales approach that can benefit from targeted outreach and high-value collaborations.

Tech stack signals Adoption of analytics, security, and web infrastructure tools implies a data-minded, compliant partner; prospective vendors can highlight robust data capabilities, monitoring, and patient privacy alignment to engage Bridge.